Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Antisoma nets £14.1mm

Executive Summary

Antisoma PLC (anticancer therapeutics) raised net proceeds of £14.1mm ($24.7mm) through an offering of 38mm new shares priced at $0.70 each. Qualifying shareholders receive one new share for every six ordinary shares at $0.70 each.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
      • Antibodies
Deal Status
  • Final
Deal Type
  • Financing
    • Other

Related Companies